Skip to main content

Table 2 Parameter estimates of the final model of linezolid

From: Acute-on-chronic liver failure alters linezolid pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study

Model parameter

 

Typical value

 

Variability

Value

95% CI

% CV

95% CI

Body clearance (L/h)

6.17

4.97; 7.55

11.6 (BSV)

60.3 (BOV)

1.43; 28.6

45.9; 80.5

Central volume of distribution (L)

27.5

22.3; 33.3

43.0 (BSV)

6.60 (BOV)

30.33; 62.5

0.89; 18.7

RRT clearance (L/h)

1.65

1.39; 1.94

33.8 (BSV)

23.4; 46.6

Inter-compartmental clearance (L/h)

9.58

7.97; 11.2

  

Peripheral volume of distribution (L)

43.7

22.3; 77.1

104.9 (BSV)

112.7 (BOV)

87.2; 142

Change in body clearance for patients with liver disease (%)

− 78.7

− 87.0; − 67.1

  

Pre-filter proportional error (%)

12.0

10.4; 14.1

  

Post-filter proportional error (%)

14.9

12.7; 16.7

  

Dialysate proportional error (%)

22.9

19.8; 26.8

  
  1. BSV Between-subject variability, BOV between-occasion variability, RRT renal replacement therapy, 95% CI 95% confidence interval, % CV Percent Coefficient of Variation